|
🐜
|
The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
10 auth.
F. A. Klok,
G. Boon,
Stefano Barco,
M. Endres,
J. Geelhoed,
S. Knauss,
...
S. Rezek,
M. Spruit,
J. Vehreschild,
B. Siegerink
|
8 |
2020 |
8
🐜
|
|
🦁
|
Mucormycosis treated with posaconazole: review of 96 case reports
11 auth.
J. Vehreschild,
A. Birtel,
M. Vehreschild,
B. Liss,
F. Farowski,
M. Kochanek,
...
M. Sieniawski,
A. Steinbach,
K. Wahlers,
G. Fätkenheuer,
O. Cornely
|
7 |
2013 |
7
🦁
|
|
🦁
|
Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
9 auth.
J. Vehreschild,
C. Müller,
F. Farowski,
M. Vehreschild,
O. Cornely,
Uwe Fuhr,
...
K. Kreuzer,
M. Hallek,
V. Kohl
|
5 |
2012 |
5
🦁
|
|
🐬
|
Current experience in treating invasive zygomycosis with posaconazole.
O. Cornely,
J. Vehreschild,
M. Rüping
|
5 |
2009 |
5
🐬
|
|
🐢
|
Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis.
10 auth.
M. Vehreschild,
David Weitershagen,
L. Biehl,
D. Tacke,
D. Waldschmidt,
U. Töx,
...
H. Wisplinghoff,
M. von Bergwelt-Baildon,
O. Cornely,
J. Vehreschild
|
5 |
2014 |
5
🐢
|
|
🐜
|
Economic burden of Clostridium difficile associated diarrhoea: a cost-of-illness study from a German tertiary care hospital
15 auth.
S. Heimann,
J. Vehreschild,
O. Cornely,
Hilmar Wisplinghoff,
M. Hallek,
R. Goldbrunner,
B. Böttiger,
T. Goeser,
A. Hölscher,
Stephan Baldus,
...
F. Müller,
Nathalie Jazmati,
S. Wingen,
B. Franke,
M. Vehreschild
|
5 |
2015 |
5
🐜
|
|
🐜
|
Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples
20 auth.
T. Boch,
M. Reinwald,
P. Postina,
O. Cornely,
J. Vehreschild,
C. Heussel,
W. Heinz,
M. Hoenigl,
S. Eigl,
T. Lehrnbecher,
...
J. Hahn,
B. Claus,
M. Lauten,
G. Egerer,
M. Müller,
Silke Will,
N. Merker,
W. Hofmann,
D. Buchheidt,
B. Spiess
|
5 |
2015 |
5
🐜
|
|
🐬
|
Invasive candidiasis and candidemia: from current opinions to future perspectives
M. Rueping,
J. Vehreschild,
O. Cornely
|
5 |
2009 |
5
🐬
|
|
🐜
|
Our 2015 approach to invasive pulmonary aspergillosis
13 auth.
B. Liss,
J. Vehreschild,
C. Bangard,
D. Maintz,
K. Frank,
S. Grönke,
G. Michels,
A. Hamprecht,
H. Wisplinghoff,
B. Markiefka,
...
K. Hekmat,
M. Vehreschild,
O. Cornely
|
4 |
2015 |
4
🐜
|
